All gliomas and half of the BrM samples had comparably low levels of these cells (<15% of CD8+ T cells) and were defined as C3 low, while the other half of BrM tumors were highly infiltrated with C3 cells (>30% of CD8+ T cells) and were classified as C3 high (Fig. 1j). This evidence concerns the gene CD8A and glioma.